[Federal Register Volume 65, Number 188 (Wednesday, September 27, 2000)]
[Notices]
[Pages 58095-58096]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-24722]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: October 17, 2000.
    Time: 9 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW., Washington, DC 
20004.
    Contact Person: Kesinee Nimit, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: October 17-18, 2000.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW., Washington, DC 
20004.
    Contact Person: Marina L. Volkov, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Treatment Research.
    Date: October 17, 2000.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW., Washington, DC 
20004.
    Contact Person: William C. Grace, Deputy Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Health Services Research.
    Date: October 18, 2000.
    Time: 11 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hotel Washington, 515 15th Street, NW., Washington, DC 
20004.
    Contact Person: Kesinee Nimit, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1432.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: November 1-2, 2000.
    Time: 9 a.m. to 4 p.m.

[[Page 58096]]

    Agenda: To review and evaluate grant applications.
    Place: Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Khursheed Asghar, Chief, Basic Sciences Review 
Branch, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Cognitive Approaches to Addictive Processes.
    Date: November 14-15, 2000.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel, 2121 P Street, NW., Washington, 
DC 20037.
    Contact Person: Marina. L. Volkov, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 
(301) 435-1433.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: November 14-16, 2000.
    Time: 9:00 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Mark Swieter, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Training and Career Development.
    Date: November 16, 2000.
    Time: 3:00 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Arlington Hyatt, 1325 Wilson Boulevard, Arlington, VA 
22209.
    Contact Person: Rita Liu, Health Scientist Administrator, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Centers Review Committee.
    Date: November 20-21, 2000.
    Time: 8:30 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, Health Scientist Administrator, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Genetics and Consequences of Nicotine Addiction.
    Date: November 21, 2000.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Rita Liu, Health Scientist Administrator, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2620.


(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: September 19, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-24722 Filed 9-26-00; 8:45 am]
BILLING CODE 4140-01-M